Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas
出版年份 2010 全文链接
标题
Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas
作者
关键词
-
出版物
CANCER
Volume 116, Issue 17, Pages 3988-3999
出版商
Wiley
发表日期
2010-05-29
DOI
10.1002/cncr.25256
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
- (2009) D A Reardon et al. BRITISH JOURNAL OF CANCER
- Bevacizumab for recurrent alkylator-refractory anaplastic oligodendroglioma
- (2009) Marc C. Chamberlain et al. CANCER
- Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas
- (2009) Philip H. Gutin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis
- (2009) Roy Torcuator et al. JOURNAL OF NEURO-ONCOLOGY
- Salvage therapy with single agent bevacizumab for recurrent glioblastoma
- (2009) Marc C. Chamberlain et al. JOURNAL OF NEURO-ONCOLOGY
- Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab
- (2009) Eudocia C. Quant et al. NEURO-ONCOLOGY
- Bevacizumab and irinotecan for recurrent oligodendroglial tumors
- (2009) S. Taillibert et al. NEUROLOGY
- Bevacizumab and chemotherapy for recurrent glioblastoma: A single-institution experience
- (2009) P. L. Nghiemphu et al. NEUROLOGY
- Paraoxonase genes and susceptibility to ALS
- (2009) D. A. Greenberg et al. NEUROLOGY
- Bevacizumab for recurrent ependymoma
- (2009) R. M. Green et al. NEUROLOGY
- Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors
- (2008) Felix Bokstein et al. CANCER
- Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas
- (2008) A. Desjardins et al. CLINICAL CANCER RESEARCH
- Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival
- (2008) A. M. Spence et al. CLINICAL CANCER RESEARCH
- Emerging antiangiogenic treatments for gliomas – efficacy and safety issues
- (2008) Jörg Dietrich et al. CURRENT OPINION IN NEUROLOGY
- Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy
- (2008) David A Reardon et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phase II Pilot Study of Bevacizumab in Combination with Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Interim Analysis of Safety and Tolerability
- (2008) Albert Lai et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Feasibility of Using Bevacizumab With Radiation Therapy and Temozolomide in Newly Diagnosed High-Grade Glioma
- (2008) Ashwatha Narayana et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Pilot Safety Study of Lenalidomide and Radiotherapy for Patients With Newly Diagnosed Glioblastoma Multiforme
- (2008) Jan Drappatz et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Bevacizumab Reverses Cerebral Radiation Necrosis
- (2008) Eric T. Wong et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Plus Irinotecan in Recurrent Glioblastoma
- (2008) Marc C. Chamberlain JOURNAL OF CLINICAL ONCOLOGY
- Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan
- (2008) Sith Sathornsumetee et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma
- (2008) Marc C. Chamberlain et al. JOURNAL OF NEURO-ONCOLOGY
- Novel anti-angiogenic therapies for malignant gliomas
- (2008) Andrew D Norden et al. LANCET NEUROLOGY
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
- (2008) Kathleen R. Lamborn et al. NEURO-ONCOLOGY
- Safety of anticoagulation use and bevacizumab in patients with glioma
- (2008) Phioanh (Leia) Nghiemphu et al. NEURO-ONCOLOGY
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now